California Institute for Regenerative Medicine
@CIRMnews
Followers
15K
Following
6K
Media
3K
Statuses
10K
Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world
California
Joined April 2010
For 20 years, CIRM has been at the forefront of regenerative medicine—funding critical research, building infrastructure, and championing patient access to clinical trials. Explore our annual report here: #CIRM #20YearsOfCIRM #RegenerativeMedicine
2
2
11
RT @KECKSchool_USC: Partnering with @USCStemCell and @CIRMnews to train the next generation of leaders in stem cell research. Since 2006, C….
0
3
0
RT @USCStemCell: 📷.Meet USC CIRM Scholar Alumna Vivian Medina, Senior Manager of Digital and Data Analytics at Takeda, who pursues her care….
0
1
0
CIRM’s DISC5 funding program supports innovative, exploratory research in #StemCell biology and #RegenerativeMedicine, focusing on interdisciplinary pairs of investigators tackling key knowledge gaps. Learn more at
0
3
6
RT @USCStemCell: Meet USC CIRM Scholar Alumnus Maksim Plikus, a professor at the University of California Irvine who studies hair biology.….
stemcell.keck.usc.edu
Maksim Plikus was still an undergraduate when he first became fascinated by the study of hair biology. His lab supervisor asked him to dissect a rat whisker, and to recombine parts of it to see if it...
0
1
0
Millions live with painful #osteoarthritis worldwide. A CIRM-funded #ClinicalTrial by Genascence reported positive early results using a #GeneTherapy approach, demonstrating safety and sustained efficacy at 12 months. Learn more at
0
2
7
RT @USCStemCell: Meet USC’s CIRM Scholar alumna Suhasni Gopalakrishnan, Director at @AllogeneTx in San Francisco. This year, a product call….
stemcell.keck.usc.edu
“I feel like I'm a person who goes with the flow,” said Suhasni Gopalakrishnan, Director at Allogene Therapeutics in San Francisco. Going with the flow has led Gopalakrishnan to many fascinating...
0
2
0
Most ALS cases have no known genetic cause. With CIRM support, Julia Kaye, PhD, at @GladstoneInst, is using patient-derived #StemCells to uncover disease mechanisms and test potential therapies for sporadic #ALS. #RareDiseases #RegenerativeMedicine.
blog.cirm.ca.gov
Research Investigator Julia Kaye, PhD, stands for a portrait in a lab at Gladstone Institutes. Photo courtesy of Gladstone Institutes. Before there can be any therapies for disease, scientists need…
0
0
1
RT @USCStemCell: $13.5 million from a CIRM Scholars program at @USCStemCell has supported and will support 110 trainees, including PhD stud….
stemcell.keck.usc.edu
To accelerate stem cell treatments to patients with unmet medical needs, the California Institute for Regenerative Medicine (CIRM) has always recognized the need to educate and train a scientific...
0
8
0
A gene therapy trial for rare immune disorder LAD-I, developed by @RocketPharma and co-led by @UCLAstemcell and backed by a $5.8M CIRM grant, restored immune function in all 9 children treated—marking a major step forward in #GeneTherapy. #RareDisease.
stemcell.ucla.edu
An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency...
0
2
17
RT @ReeveFoundation: 📅 Save the date! The 3rd Annual Spinal Cord Injury Investor Symposium returns as a virtual event on June 27, 2025, pre….
0
1
0
Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a #StemCellTherapy that could transform #epilepsy treatment without surgery or tissue damage. Learn more on our blog: #RegenerativeMedicine #Biotech #California #ClinicalTrial
0
1
6
RT @GladstoneInst: The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular re….
0
1
0
🚨REMINDER: Prospective DISC4 applicants, the Pre-Submission Form deadline is June 16 at 2 PM.The DISC4 Awards support large, cross-disciplinary teams working on innovative ways to understand and treat human disease. Learn more at
0
0
2
🚨 REMINDER: Preclinical Development (PDEV) Pre-submission forms are due June 12.
0
0
0
CIRM’s Clinical Trial (CLIN2) Awards accelerate the development of regenerative medicine therapies for serious unmet medical needs. Our goal is to help these therapies progress toward FDA approval, improving patient care in California. Learn more at
0
0
1
CIRM was proud to participate in Stanford’s @iWISH_Talks, where our Chief Science Officer, Dr. Rosa Canet-Avilés shared her journey across neuroscience, stem cell science, and leadership. Thank you @stanfordCVI for hosting!
0
4
14
The Preclinical Development (PDEV) Awards accelerate the development of stem cell & genetic therapies. This funding supports preclinical work, from candidate optimization to FDA IND clearance, helping researchers bring treatments to patients. Learn more:
0
0
0
CIRM's new funding program, the DISC4 Awards, is designed to support large, cross-disciplinary research teams advancing innovative approaches to understand and treat human disease. Learn more about the DISC4 Awards and sign up for email updates at
0
0
8
CIRM is excited to announce our new funding opportunities, the Preclinical Development (PDEV) and Clinical Trial (CLIN2) Awards! . Learn more about both funding programs on our website at
0
0
4
CIRM is now on BlueSky! Follow us for updates on stem cell and gene therapy research, CIRM-funded clinical trials, and the latest breakthroughs in regenerative medicine. . #RegenerativeMedicine #BlueSky
0
1
5